Total Payments
$390,061
2024 Payments
$1,799
Companies
20
Transactions
389
Medicare Patients
281
Medicare Billing
$30,057
Payment Breakdown by Category
Other$292,128 (74.9%)
Consulting$57,700 (14.8%)
Travel$19,179 (4.9%)
Research$10,220 (2.6%)
Food & Beverage$8,965 (2.3%)
Education$1,869 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $266,578 | 114 | 68.3% |
| Consulting Fee | $57,700 | 20 | 14.8% |
| Honoraria | $25,550 | 13 | 6.6% |
| Travel and Lodging | $19,179 | 77 | 4.9% |
| Unspecified | $10,220 | 1 | 2.6% |
| Food and Beverage | $8,965 | 160 | 2.3% |
| Education | $1,869 | 4 | 0.5% |
Payments by Type
General
$379,841
388 transactions
Research
$10,220
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $126,085 | 71 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $93,979 | 98 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $68,079 | 65 | $0 (2022) |
| US WorldMeds, LLC | $49,586 | 93 | $0 (2020) |
| Adamas Pharmaceuticals, Inc. | $14,518 | 11 | $0 (2019) |
| Eli Lilly and Company | $10,220 | 1 | $0 (2019) |
| Acorda Therapeutics, Inc | $7,921 | 7 | $0 (2019) |
| MDD US Operations, LLC | $6,651 | 13 | $0 (2023) |
| Lundbeck LLC | $5,902 | 6 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $5,691 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,799 | 8 | Amneal Pharmaceuticals LLC ($1,691) |
| 2023 | $4,229 | 17 | ACADIA Pharmaceuticals Inc ($2,023) |
| 2022 | $20,806 | 27 | Neurocrine Biosciences, Inc. ($15,861) |
| 2021 | $46,437 | 37 | Neurocrine Biosciences, Inc. ($36,359) |
| 2020 | $45,970 | 44 | Neurocrine Biosciences, Inc. ($22,118) |
| 2019 | $101,198 | 113 | ACADIA Pharmaceuticals Inc ($23,588) |
| 2018 | $83,607 | 74 | ACADIA Pharmaceuticals Inc ($39,079) |
| 2017 | $86,015 | 69 | ACADIA Pharmaceuticals Inc ($59,394) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Education | In-kind items and services | $1,112.00 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Education | In-kind items and services | $556.00 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROLOGY | ||||||
| 04/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Neuropsychiatry | ||||||
| 04/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Neurology | ||||||
| 02/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Neurology | ||||||
| 12/14/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/21/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neuropsychiatry | ||||||
| 10/13/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Neurology | ||||||
| 08/04/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.88 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/25/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Consulting Fee | Cash or cash equivalent | $1,760.00 | General |
| Category: NEUROLOGY | ||||||
| 07/21/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/12/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.52 | General |
| 05/13/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $64.17 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/03/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/03/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/25/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Neuropsychiatry | ||||||
| 04/24/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Neuropsychiatry | ||||||
| 04/17/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/05/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug) | Consulting Fee | Cash or cash equivalent | $265.00 | General |
| Category: Neuropsychiatry | ||||||
| 03/17/2023 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: Neurology | ||||||
| 02/28/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/19/2023 | Cala Health, Inc. | CALA TRIO (Device) | Food and Beverage | In-kind items and services | $49.85 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $10,220 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 55 | 63 | $15,800 | $6,804 |
| 2022 | 2 | 33 | 36 | $8,790 | $3,881 |
| 2021 | 3 | 73 | 114 | $40,299 | $7,626 |
| 2020 | 4 | 120 | 185 | $58,748 | $11,746 |
Total Patients
281
Total Services
398
Medicare Billing
$30,057
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 40 | $6,600 | $3,493 | 52.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $9,200 | $3,310 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,985 | $2,282 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 17 | $2,805 | $1,599 | 57.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2021 | 18 | 36 | $26,994 | $4,168 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 51 | $10,659 | $3,034 | 28.5% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 14 | 27 | $2,646 | $424.22 | 16.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Facility | 2020 | 18 | 46 | $34,356 | $5,420 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 77 | 90 | $18,810 | $5,014 | 26.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,956 | $763.88 | 39.1% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2020 | 14 | 37 | $3,626 | $548.48 | 15.1% |
About Dr. Thyagarajan Subramanian, MD
Dr. Thyagarajan Subramanian, MD is a Neurology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003864091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thyagarajan Subramanian, MD has received a total of $390,061 in payments from pharmaceutical and medical device companies, with $1,799 received in 2024. These payments were reported across 389 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($266,578).
As a Medicare-enrolled provider, Subramanian has provided services to 281 Medicare beneficiaries, totaling 398 services with total Medicare billing of $30,057. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Hershey, PA
- Active Since 05/04/2006
- Last Updated 11/22/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003864091
Products in Payments
- NUPLAZID (Drug) $126,085
- INGREZZA (Drug) $80,227
- AUSTEDO (Drug) $54,886
- Xadago (Drug) $30,339
- GOCOVRI (Drug) $16,278
- MYOBLOC (Biological) $14,768
- ONGENTYS (Drug) $10,816
- SD809-TD (Drug) $8,217
- INBRIJA (Drug) $7,021
- NORTHERA (Drug) $5,902
- SD809-HD (Drug) $4,775
- APOKYN (Drug) $4,011
- RYTARY (Drug) $4,000
- Ongentys (Drug) $1,911
- NOURIANZ (Drug) $1,135
- ONGENTYS 50MG CAPSULES 30 (Drug) $1,112
- Briviact (Drug) $99.77
- CALA TRIO (Device) $49.85
- CREXONT (Drug) $23.24
- NURTEC ODT (Drug) $23.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hershey
Gary Thomas, Md, MD
Neurology — Payments: $178,553
Neurology $178,553
Dr. Sol De Jesus, M.d, M.D
Neurology — Payments: $126,431
Neurology $126,431
Dr. Donald Dworek, D.o, D.O
Neurology — Payments: $38,455
Neurology $38,455
Dr. James Grogan, M.d, M.D
Neurology — Payments: $25,160
Neurology $25,160
Alain Zingraff Lekoubou Looti, Md, MD
Neurology — Payments: $20,864
Neurology $20,864
Dr. Venkata Jakkampudi, M.d, M.D
Neurology — Payments: $8,334
Neurology $8,334